Marty Coyne Email & Phone Number

Boonton, New Jersey, Us

As a co-founder and CEO, I set our strategic direction, drive innovation, and work directly with clients to tackle complex challenges in specialty pharmaceuticals.Much of our work focuses on understanding patients and caregivers—their current behaviors and how they will use or misuse devices. We’re not just researchers; we’re inventors. We test clients' concepts with patients and caregivers or help them invent and patent solutions to address unmet needs and treatment barriers.With extensive corporate experience, including C-suite and Board-level engagement, I excel at building business cases for capital investments in new devices, scaleup, and regional expansions. Our reputation at Matchstick is built through word of mouth. We take on “impossible” problems and develop bespoke (often patentable) solutions. We combine startup agility with corporate professionalism, delivering at speed with a deeply personal, high-touch client experience.I’m also passionate about leadership development, particularly for emerging leaders. Our talent programs have been studied by small and large firms, giving me a unique perspective on preparing the next generation of medical device leaders.

The Subcutaneous Drug Development & Delivery Consortium was established in 2018 to fundamentally improve subcutaneous drug development and delivery. Motivated by this shared goal, members have come together to address key issues in the subcutaneous industry and expand subcutaneous technology use to improve patient outcomes.

Kingston, Ri, Us

Franklin Lakes, New Jersey, Us

Selected by senior leadership to lead commercialization of AutoShield Duo safety engineered pen needle devices, a critical product launch for the company. Full responsibility for go-to-market strategy, incremental sales force, and financial performance. Key contributor to manufacturing strategy and implementation. Developed and executed strategies to increase adoption and accelerate market conversion, including efforts with pharmaceutical partners.Led overall marketing efforts for all insulin delivery products used in hospital and long term care settings. Developed product roadmaps, managed existing products, and had accountability for financial performance (revenue, spend, and profitability). Key SME for acute care setting within Diabetes Care.Represented BD Diabetes Care and the BD Medical segment in meetings, seminars, and conferences related to safe injection practices. I frequently represented BD in key stakeholder meetings with OSHA, US and non-US government officials, and other regulators.

Franklin Lakes, New Jersey, Us

Led plastic prefillable syringe strategy development for key segments including biotech, cosmetic surgery, and acute care generics. Led user research, user needs generation, and pharma partner engagement for next generation product development for plastics.Built business case and user requirements for Sterifill for Syringe Pumps, and Sterifill for Biotech.

Franklin Lakes, New Jersey, Us

Responsible for complete marketing management of flagship BD Hypodermic and Pharmacy product lines ($200+ MM annual revenue). Work included sales training program development and execution, competitive intelligence and strategy development. Worked with customers to identify new ways to avoid medication errors in parenteral drug delivery, resulting in six issued US patents.

Franklin Lakes, New Jersey, Us

Key contributor to conversion of the US market to safety-engineered anti-needlestick products following passage of the 2001 Needlestick Safety and Prevention Act.Responsible for product management of BD Safety Lok, BD Eclipse, and BD SafetyGlide safety hypodermic needles. Managed all aspects of product marketing to ensure the achievement of financial expectations. Key contributor to product development, manufacturing, and quality strategies. Generated significant IP around safety-engineered products to address opportunities as market conversion progressed.Extensive global experience (with BD and HCP groups) to share the US safety conversion experience, and deliver market- and region- specific approaches to drive safety product adoption worldwide.

Kalamazoo, Mi, Us

Design engineering and product management responsibility for existing hip replacement implants and orthopedic bone cements. Led US commercial launch of Simplex with Tobramycin, an antibiotic bone cement with novel manufacturing and regulatory approaches and an early combination product. Translated scientific and clinical data into effective market positioning, then developed training materials and led US rollout. Engaged directly with surgeon thought leaders and customers to drive adoption of this market-leading product.Key contributor towards Restoration Modular implants and instrument system concept development, where I managed key surgeon designer relationships, user input, and concept refinement. Numerous patents awarded for unique implantation instruments allowing in situ adjustment of implants. Developed full financial case for investment in instruments and implants.

Master Of Business Administration - Mba, Leadership, General Management, Strategy

Bachelor Of Engineering - Be, Mechanical Engineering